Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gautier Marcq

Showing results (51-60 of 94) with videos related to

Pageof 10
Sort By:
European Urology Oncology|February 7, 2024
Benefit of Neoadjuvant Cisplatin-based Chemotherapy for Invasive Bladder Cancer Patients Treated with Radiation-based Therapy in a Real-world Setting: An Inverse Probability Treatment Weighted AnalysisRonald Kool, Alice Dragomir, Girish S Kulkarni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2024
Benefit of Whole-Pelvis Radiation for Patients With Muscle-Invasive Bladder Cancer: An Inverse Probability Treatment Weighted AnalysisGautier Marcq, Ronald Kool, Alice Dragomir, et al.
European Urology Oncology|April 2, 2023
Radiation-based Therapy for Muscle-invasive Bladder Cancer: Contemporary Outcomes Across Tertiary CentersRonald Kool, Gautier Marcq, Rodney H Breau, et al.
The Oncologist|July 3, 2024
Cisplatin eligibility in the neoadjuvant setting of patients with muscle-invasive bladder cancer undergoing radical cystectomyRenate Pichler, Josef Fritz, Andrea Mari, et al.
European Urology Focus|February 2, 2025
Oncologic Outcomes of Endoscopic Management of Upper Tract Urothelial Carcinoma: A Systematic Review and Pooled Analysis from the EAU-YAU Urothelial Working GroupAndrea Gallioli, Alessandro Uleri, Paolo Verri, et al.
BJU International|October 17, 2022
Surgical checklist adherence across urology expertise levels impacts transurethral resection of bladder tumour quality indicatorsFrancesco Del Giudice, David D'Andrea, Benjamin Pradere, et al.
International Journal of Radiation Oncology, Biology, Physics|August 26, 2024
Effect of Complete Transurethral Resection on Oncologic Outcomes After Radiation Therapy for Muscle-Invasive Bladder CancerPier Paolo Avolio, Ronald Kool, Bobby Shayegan, et al.
Cancers|December 11, 2022
Oncological Outcomes for Patients Harboring Positive Surgical Margins Following Radical Cystectomy for Muscle-Invasive Bladder Cancer: A Retrospective Multicentric Study on Behalf of the YAU Urothelial GroupGautier Marcq, Luca Afferi, Yann Neuzillet, et al.
The Journal of Urology|July 25, 2024
The Impact of Histologic Subtypes on Clinical Outcomes After Radiation-Based Therapy for Muscle-Invasive Bladder CancerDaniel Halstuch, Ronald Kool, Gautier Marcq, et al.
European Urology Oncology|January 25, 2026
Risk of Recurrence and Progression After Endoscopic Kidney-sparing Surgery for Upper Tract Urothelial CarcinomaAndrea Gallioli, Francesco Di Bello, Fabio Zattoni, et al.
Pageof 10

Showing results (51-60 of 94) with videos related to

Sort By:
Pageof 10
European Urology Oncology|February 7, 2024
Benefit of Neoadjuvant Cisplatin-based Chemotherapy for Invasive Bladder Cancer Patients Treated with Radiation-based Therapy in a Real-world Setting: An Inverse Probability Treatment Weighted AnalysisRonald Kool, Alice Dragomir, Girish S Kulkarni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2024
Benefit of Whole-Pelvis Radiation for Patients With Muscle-Invasive Bladder Cancer: An Inverse Probability Treatment Weighted AnalysisGautier Marcq, Ronald Kool, Alice Dragomir, et al.
European Urology Oncology|April 2, 2023
Radiation-based Therapy for Muscle-invasive Bladder Cancer: Contemporary Outcomes Across Tertiary CentersRonald Kool, Gautier Marcq, Rodney H Breau, et al.
The Oncologist|July 3, 2024
Cisplatin eligibility in the neoadjuvant setting of patients with muscle-invasive bladder cancer undergoing radical cystectomyRenate Pichler, Josef Fritz, Andrea Mari, et al.
European Urology Focus|February 2, 2025
Oncologic Outcomes of Endoscopic Management of Upper Tract Urothelial Carcinoma: A Systematic Review and Pooled Analysis from the EAU-YAU Urothelial Working GroupAndrea Gallioli, Alessandro Uleri, Paolo Verri, et al.
BJU International|October 17, 2022
Surgical checklist adherence across urology expertise levels impacts transurethral resection of bladder tumour quality indicatorsFrancesco Del Giudice, David D'Andrea, Benjamin Pradere, et al.
International Journal of Radiation Oncology, Biology, Physics|August 26, 2024
Effect of Complete Transurethral Resection on Oncologic Outcomes After Radiation Therapy for Muscle-Invasive Bladder CancerPier Paolo Avolio, Ronald Kool, Bobby Shayegan, et al.
Cancers|December 11, 2022
Oncological Outcomes for Patients Harboring Positive Surgical Margins Following Radical Cystectomy for Muscle-Invasive Bladder Cancer: A Retrospective Multicentric Study on Behalf of the YAU Urothelial GroupGautier Marcq, Luca Afferi, Yann Neuzillet, et al.
The Journal of Urology|July 25, 2024
The Impact of Histologic Subtypes on Clinical Outcomes After Radiation-Based Therapy for Muscle-Invasive Bladder CancerDaniel Halstuch, Ronald Kool, Gautier Marcq, et al.
European Urology Oncology|January 25, 2026
Risk of Recurrence and Progression After Endoscopic Kidney-sparing Surgery for Upper Tract Urothelial CarcinomaAndrea Gallioli, Francesco Di Bello, Fabio Zattoni, et al.
Pageof 10